Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytegen

Cytegen?uq=PEM9b6PF
2015 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of discovery platform designed to increase the human healthspan by reversing age-related decline in the body. The company's therapies target age-related health decline and neurodegenerative diseases like MS and Parkinson's as well as some other rare diseases, enabling patients to improve cellular metabolism.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 1225 Discovery Parkway
  • Wauwatosa, WI 53226
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cytegen’s full profile, request a free trial.

Cytegen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 00.000 Completed Out of Business
4. Early Stage VC 12-Apr-2018 000 00.000 Completed Startup
3. Accelerator/Incubator 00000 Completed Startup
2. Grant 01-Jan-2017 $211K $350K Completed Startup
1. Seed Round 06-Oct-2015 $350K $350K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cytegen Executive Team (2)

Name Title Board
Seat
Contact
Info
Nuray Ugras Ph.D Co-Founder & President
Blake Hill Co-Founder & Chief Scientific Officer